Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye

American Journal of Ophthalmology

Volumn 130, Issue 2, 2000, Pages 151-159

  Sponsel, William Eric ^a   Mensah, Josepha ^a   Kiel, J W ^a   Remky, A ^a   Trigo, Yolanda ^a   Baca, W ^a   Friberg, T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; PLACEBO; TIMOLOL MALEATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLAUCOMA; HUMAN; HYDRODYNAMICS; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; TONOMETRY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; COMPARATIVE STUDY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GELS; HUMAN; INTRAOCULAR PRESSURE; MALE; MIDDLE AGE; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; PULSATILE FLOW; SCLERA; SUPPORT, NON-U.S. GOV'T; TIMOLOL; TONOMETRY; VENOUS PRESSURE;

EID: 0033825805     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00401-3     Document Type: Article

References (26)

1. Camras C.B., Alm A., Watson P.G., et al. Latanoprost, a prostaglandin analog, for glaucoma therapy efficacy and safety after 1 year of treatment in 198 patients. Ophthalmology. 103:1996;1916-1924.
2. Toris C.B., Camras C.B., Yablonski M.E. Effects of PhXA41, a new prostaglandin F2α analog, on aqueous humor dynamics in human eyes. Ophthalmology. 100:1993;1297-1304.
3. Bill A. Conventional and uveoscleral drainage of aqueous humor in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressure. Exp Eye Res. 5:1966;45-55.
4. Alm A., Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost once daily, evening or morning a comparison with timolol. Ophthalmology. 102:1995;1743-1752.
5. Watson P., Stjernschantz J. A six-month, randomized, double masked study comparing latanoprost with timolol in open angle glaucoma and ocular hypertension. Ophthalmology. 103:1996;126-137.
6. Camras C.B. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma a six-month, masked, multicenter trial in the United States. Ophthalmology. 103:1996;138-147.
7. Coakes R.L., Brubaker R.F. The mechanism of timolol in lowering intraocular pressure. Arch Ophthalmol. 96:1978;2045-2048.
8. Rulo A.H., Greve E.L., Geijssen H.C., Hoyng P.F. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma. Ophthalmology. 103:1996;1276-1282.
9. Drance S.M., Anderson D.R., Schulzer M., et al. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Ophthalmology. 126:1998;487-497.
10. McKibben M., Menage M.J. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye. 13:1999;31-34.
11. Silver D.A., Farrell R.A. Validity of pulsatile ocular blood flow measurements. Surv Ophthalmol. 38:(suppl):1994;S72-S80.
12. Fontana L., Poinoosawmy D., Bunce C.V., O'Brien C., Hitchings R.A. Pulsatile ocular blood flow investigation in asymmetric normal tension glaucoma and normal subjects. Br J Ophthalmol. 82:1998;731-736.
13. James C.B. Effect of trabeculectomy on pulsatile ocular blood flow. Br J Ophthalmol. 78:1994;818-822.
14. Boles-Carenini A., Sibour G., Boles-Carenini B. Differences in the long-term effect of timolol and betaxolol on the pulsatile ocular blood flow. Surv Ophthalmol. 38:(suppl):1994;S118-S124.
15. Bosem M.E., Lusky M., Weinreb R.N. Short-term effects of levobunolol on ocular pulsatile flow. Am J Ophthalmol. 114:1992;280-286.
16. Grajewski A.L., Ferrari-Dileo G., Feuer W.J., Anderson D.R. Beta-adrenergic responsiveness of choroidal vasculature. Ophthalmology. 98:1991;989-995.
17. Kiel J.W., Patel P. Effects of timolol and betaxolol on choroidal blood flow in the rabbit. Exp Eye Res. 67:1998;501-507.
18. Kitaya N., Yoshido A., Ishiko S., et al. Effect of timolol and UF-021 (a prostaglandin-related compound) on pulsatile ocular blood flow in normal volunteers. Ophthalmic Res. 29:1997;139-144.
19. Lachkar Y., Migdal C., Dhanjil S., Griffin M. Effect of brimonidine tartrate on ocular hemodynamic measurements. Arch Ophthalmol. 116:1998;1591-1594.
20. Schmidt K.-G., Von Rückmann A.V., Pillunat L.E. Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma. Br J Ophthalmol. 82:1998;768-772.
21. Friberg T.R. Portable transducer for measurement of episcleral venous pressure. Am J Ophthalmol. 102:1986;396-397.
22. Drance S.M., Chrichton A., Mills R.P. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma. Am J Ophthalmol. 125:1997;585-592.
23. Nicolela M.T., Buckley A.R., Walman B.E., Drance S.M. Effects of timolol and latanoprost on velocity of the retrobulbar vessels. Am J Ophthalmol. 122:1996;782-789.
24. Harris A., Spaeth G.L., Sergott R.C., et al. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma. Am J Ophthalmol. 120:1995;168-175.
25. Baxter G.M., Williamson T.H., McKillop G., Dutton G.N. Color Doppler ultrasound of orbital and optic nerve blood flow, effects of posture and timolol 0.5%. Invest Ophthalmol Vis Sci. 33:1992;604-610.
26. Astin M., Stjernschantz J., Selen G. Role of nitric oxide in PGF2α-induced ocular hyperemia. Exp Eye Res. 59:1994;401-408.